Related Experiment Videos
Measles virus 1998-2002: progress and controversy
1Division of Basic Science, Fox Chase Cancer Center, 7701 Burholme Avenue, Philadelphia, Pennsylvania 19111, USA. gf_rall@fccc.edu
Annual Review of Microbiology
|October 7, 2003
Summary
Measles virus (MV) remains a significant global killer, often indirectly through opportunistic infections due to MV-induced immunosuppression. Ongoing research addresses MV pathogenesis, receptor usage, and vaccine safety controversies.
Area of Science:
- Virology
- Immunology
- Epidemiology
Background:
- Measles virus (MV) is a leading cause of infectious disease mortality worldwide, comparable to Human Immunodeficiency Virus (HIV)-1.
- MV-induced immunosuppression can lead to fatal opportunistic infections, and in rare instances, neurodegenerative diseases.
- Despite media focus on other viruses, MV remains a critical global health concern.
Purpose of the Study:
- To review major advances in understanding measles virus (MV) biology and pathogenesis.
- To discuss current debates and controversies surrounding MV, including its role in other diseases and vaccine safety.
- To highlight areas for future research in MV.
Main Methods:
- Review of scientific literature from 1998-2002.
- Analysis of progress in animal models, reverse genetics, and immunological assays.
- Discussion of existing controversies and unresolved questions in MV research.
Main Results:
- Significant progress has been made in understanding MV receptor usage and the cellular basis of immunosuppression.
- The suspected role of MV in nonviral diseases like multiple sclerosis and Paget's disease is under investigation.
- Controversies regarding MV vaccine safety persist and require further research.
Conclusions:
- Despite advances, significant questions remain regarding MV pathogenesis and its broader health implications.
- Further research is crucial to address debates on MV's role in chronic diseases and vaccine safety.
- Continued investigation into MV biology is essential for public health strategies.